Aptar CSP Technologies Changes Name to Aptar Active Material Science
 Aptar CSP Technologies is changing its name to Aptar Active Material Science. This new name reinforces Aptar’s position as a trusted leader in active [...]
Aptar CSP Thought Leadership Featured in the Pharmaceutical Technology Magazine
Pharmaceutical packaging is evolving in response to growing product complexity, extended global supply chains, and increasing expectations around quality and patient safety. Today, packaging must [...]
Aptar CSP Technologies’ Dual-Guard Active Material Science Technology Wins 2025 Pharma Innovation Award
Aptar CSP Technologies is proud to announce that its Dual-Guard Active Material Science Technology has been honored with a Pharma Innovation Award by Pharma Manufacturing [...]
Aptar CSP Technologies’ Dual-Active Material Science Technology Simultaneously Controls Moisture and Oxygen for Pharmaceutical Drugs and Medical Devices
Dual-active material science solution is ideal for sensitive formulations Auburn, AL, July 8, 2025 – Aptar CSP Technologies, part of AptarGroup, Inc. and a leader [...]
Aptar CSP Technologies Expands Service Offerings with Launch of cGMP Early-Stage Clinical Manufacturing Site for Tablet and Capsule-Based Drug Products
New site accelerates implementation of Activ-Blister™ technology for mitigating degradation and impurities risk, including nitrosamine formation Auburn, AL, May 5, 2025 – Aptar CSP Technologies, [...]
Aptar CSP Technologies Honored with IndiaStar 2024 Awards for Excellence in Packaging Innovation
Aptar CSP Technologies has been awarded the prestigious IndiaStar 2024 Awad by the Indian Institute of Packaging (IIP) for its outstanding contribution to innovative packaging [...]
Aptar CSP Technologies Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices
Crystal Lake, Illinois, October 22, 2024 – AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, announced [...]
Aptar CSP Technologies’ N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
N-Sorb leverages company’s proven 3-Phase Activ-Polymer™ platform technology to address recent concerns related to N-nitrosamine impurities in pharmaceuticals.  Auburn, AL, September 23, 2024 – [...]
Aptar CSP’s Article on Targeting Nitrosamine Precursors Featured in ONdrugDelivery’s Issue
Check out our article on Targeting Nitrosamine Precursors with Novel Active Material Science Scavenger Technologies that is featured in the latest issue of ONdrugDelivery! Our [...]
